PCS Research Technology, Inc. Sagient Research Products About Us Contact Us
Sagient Research Systems Products About Us Contact Us Company News PlacementTracker BiomedTracker CatalystTracker  

Shareholder Information

In January 2006, Sagient Research Systems completed a "going private transaction" and the company now operates as a private enterprise. We no longer make our financial information publicly available and our stock no longer trades on the OTC-BB exchange.

For a complete description of our going private transaction, please review the Information Statement we filed with the SEC by clicking here.

The going private transaction involved the company acquiring the shares of holders with 101 or fewer shares of our common stock at a price of $0.12 per share.

If you owned 101 or fewer shares of our common stock
If you owned 101 or fewer shares of our common stock prior to our going private transaction, you are no longer a shareholder of Sagient Research. Your shares have been acquired for a price of $0.12 per share. To receive your purchase price, you must submit your original stock certificate to our exchange agent as follows:

CORPORATE STOCK TRANSFER, INC.
3200 Cherry Creek South Drive
Suite 430
Denver, Colorado 80209
Phone: 303-282-4800
Fax: 303-282-5800
Attn: Carylyn Bell

Upon receipt of your original stock certificate, our exchange agent is authorized to immediately pay out your acquisition price of $0.12 per share.

If you owned more than 101 shares of our common stock
If you owned more than 101 shares of our common stock prior to our going private transaction, you are still a shareholder of Sagient Research. Your shares do not trade publicly and no regular financial information will be made available to you in the future. You continue to have the same ownership, voting, distribution, and liquidation rights that you had when the company was publicly trading.

The company will endeavor to make periodic updates available to our verified shareholders. To check on your status as a verified shareholder or for any further questions about your shares, please contact us by clicking here.